The reason it is not #1 comes down to pricing transparency
This speed represents a dramatic improvement over insurance-based treatment, where prior authorization and coverage determinations can take weeks or months
What continuity of care actually buys The value of a subscription is not the drug alone it is the wrap-around
However, if you have missed two or more doses in the same month or are struggling with consistent adherence, reaching out to your care team allows them to assess barriers and adjust your support plan
BPC-157 is not specifically named on the WADA Prohibited List as a separately listed substance, but as a non-approved substance with no marketing authorization it may fall under WADA section S0 (Non-Approved Substances), which prohibits substances not addressed by other sections of the List that have no current approval for human therapeutic use
This is clinically significant because visceral fat drives insulin resistance, inflammation, and cardiovascular risk far more than subcutaneous fat
.webp)
